Chemours Co
CC · XNYSCIK 1627223fmd_17PMP0BPZB762CRADXZC82AXTVManufacturing · Chemicals & Allied ProductsTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 5,400 | 6,183 | 6,638 | 5,526 | 4,969 | 6,345 | 6,831 | 6,078 | 5,782 | 5,808 |
| Cost of revenue | 4,297 | 4,438 | 4,667 | 4,463 | 3,902 | 4,964 | 5,215 | 4,776 | 4,640 | 4,906 |
| Net interest income | (219) | (214) | (195) | (208) | – | – | – | – | – | – |
| Gross profit | 1,103 | 1,745 | 1,971 | 1,063 | 1,067 | 1,381 | 1,616 | 1,302 | 1,142 | 902 |
| Research and development | 81 | 81 | 82 | 80 | 93 | 107 | 118 | 108 | 109 | 108 |
| Selling, general and administrative | 946 | 626 | 657 | 548 | 527 | 592 | 710 | 1,286 | 598 | 799 |
| Total operating expenses | 1,197 | 764 | 788 | 715 | 700 | 705 | 844 | 1,547 | 823 | 966 |
| Operating income | (94) | 981 | 1,183 | 348 | 367 | 676 | 772 | (245) | 319 | (64) |
| Interest expense | 219 | 214 | 195 | 208 | 210 | 185 | 163 | 208 | 263 | 269 |
| Other non-operating income (expense) | 267 | 113 | 162 | (293) | 21 | 163 | 70 | 91 | 8 | 26 |
| Income before taxes | (11) | 912 | 1,155 | (124) | 179 | 676 | 741 | (318) | 106 | (277) |
| Income tax expense | (18) | 165 | 159 | (72) | (40) | 68 | 163 | (66) | 37 | 109 |
| Net income from continuing operations | 7 | 747 | 996 | (52) | 219 | 608 | 578 | (252) | 69 | (386) |
| Net income | 7 | 746 | 995 | (52) | 219 | 608 | 578 | (253) | 69 | (386) |